متابعة
Manish Hudlikar
Manish Hudlikar
Senior Scientist-II, Discovery Chemistry, Merck & Co. South San Francisco, CA
بريد إلكتروني تم التحقق منه على merck.com - الصفحة الرئيسية
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
Novel route for rapid biosynthesis of copper nanoparticles using aqueous extract of Calotropis procera L. latex and their cytotoxicity on tumor cells
S Harne, A Sharma, M Dhaygude, S Joglekar, K Kodam, M Hudlikar
Colloids and Surfaces B: Biointerfaces 95, 284-288, 2012
2112012
Green synthesis of TiO2 nanoparticles by using aqueous extract of Jatropha curcas L. latex
M Hudlikar, S Joglekar, M Dhaygude, K Kodam
Materials Letters 75, 196-199, 2012
1762012
Latex-mediated synthesis of ZnS nanoparticles: green synthesis approach
M Hudlikar, S Joglekar, M Dhaygude, K Kodam
Journal of Nanoparticle Research 14, 1-6, 2012
1272012
Novel route for rapid biosynthesis of lead nanoparticles using aqueous extract of Jatropha curcas L. latex
S Joglekar, K Kodam, M Dhaygude, M Hudlikar
Materials letters 65 (19-20), 3170-3172, 2011
902011
Controlled multi‐functionalization facilitates targeted delivery of nanoparticles to cancer cells
MS Hudlikar, X Li, IA Gagarinov, N Kolishetti, MA Wolfert, GJ Boons
Chemistry–A European Journal 22 (4), 1415-1423, 2016
302016
Exploring Strain-Promoted 1,3-Dipolar Cycloadditions of End Functionalized Polymers
GJB Petr A. Ledin, Nagesh Kolishetti, Manish Hudlikar
Chemistry A European Journal 20, 8753-8760, 2014
102014
Exploration of bromodomain ligand-linker conjugation sites for efficient CBP/p300 heterobifunctional degrader activity
CJO Manish Hudlikar, Praveen Kumar Tiwari, Sai Reddy Doda, Raghu Vannam ...
Bioorganic & Medicinal Chemistry Letters 102, 129676-129681, 2024
2024
WO2023056069_Degrader antibody conjugates and methods of using the same
PJSCJ Manish Hudlikar, Ed Ha, Aaron Mallek, Gabriel Gonzalez
US Patent WO2,023,056,069, 2023
2023
WO2022204568_Maytansine antibody-conjugates and methods of using the same
M Hudlikar, E Ha, P Jaminet, SC Jaminet, B Lutz
US Patent PCT/US2022/022,041, 2022
2022
WO2022026915_Anti-TM4SF1 antibody-drug conjugates comprising cleavable linkers and methods of using the same
SCJ Manish Hudlikar, Edward Ha, Paul Jaminet
US Patent App. 63/350,349, 2022
2022
Novel ANTI-TM4SF1 antibody-drug conjugates and Methods of using the same
M HUDLIKAR, EH JAMINET, Paul A. JAMINET, Shou-Ching S. HA
US Patent PCT/US2020/020,207, 2021
2021
ANTI-TM4SF1 antibody-drug conjugates comprising cleavable linkers and methods of using the same
MS JAMINET, Paul A. JAMINET, Shou-Ching S. HA, Edward HUDLIKAR, ...
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2022026915&_cid …, 2021
2021
WO2021222783_ANTI-TM4SF1 antibody drug conjugates and methods of using the same
M HUDLIKAR, EH JAMINET, Paul A. JAMINET, Shou-Ching S. HA
US Patent PCT/US2021/030,226, 2021
2021
WO2021195598_Degrader antibody conjugates and methods of using the same
MS HUDLIKAR, ...
US Patent PCT/US2021/024,535, 2021
2021
WO2020176794_Antibody drug conjugates comprising anti-TM4SF1 antibodies and methods of using the same
EH HUDLIKAR, Manish, JAMINET, Paul A. JAMINET, Shou-Ching S. HA
US Patent PCT/US2020/020,207, 2020
2020
Methods for the Preparation and Delivery of Highly Potent Paclitaxel Analogs through Site-Specific Antibody-Drug Glycoconjugates
M Hudlikar, GJ Boons, X Li
US Patent App. 62/561,027, 2017
2017
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–16